지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 저널정보
- 영남대학교 의과대학 Journal of Yeungnam Medical Science Yeungnam University Journal of Medicine 제38권 제3호
- 발행연도
- 2021.1
- 수록면
- 251 - 257 (7page)
이용수
초록· 키워드
오류제보하기
Vedolizumab (VDZ) has been approved for the treatment of inflammatory bowel diseases (IBDs) in patients aged ≥18 years. We report a case of a pediatric patient with Crohn disease (CD) who was successfully treated with VDZ. A 16-year-old female developed severe active pulmonary tuberculosis (TB) during treatment with infliximab (IFX). IFX was stopped, and TB treatment was started. After a 6-month regimen of standard TB medication, her pulmonary TB was cured; however, gastrointestinal symptoms developed. Due to the concern of the patient and parents regarding TB reactivation on restarting treatment with IFX, VDZ was started off-label. After the second dose of VDZ, the patient was in clinical remission and her remission was continuously sustained. Ileocolonoscopy at 1-year after VDZ initiation revealed endoscopic healing. Therapeutic drug monitoring conducted during VDZ treatment showed negative antibodies to VDZ. No serious adverse events occurred during the VDZ treatment. This is the first case report in Korea demonstrating the safe and effective use of VDZ treatment in a pediatric CD patient. In cases that require recommencement of treatment with biologics after recovery of active pulmonary TB caused by anti-tumor necrosis factor agents, VDZ may be a good option even in pediatric IBD.
목차
등록된 정보가 없습니다.
참고문헌 (3)
참고문헌 신청
Ben Kang / 2018 / Early Biologic Treatment in Pediatric Crohn’s Disease: Catchingthe Therapeutic Window of Opportunity in Early Disease by Treat-to-Target / Pediatric Gastroenterology, Hepatology & Nutrition 21(1):1~11
Dong Il Park / 2018 / Asian Organization for Crohn’s and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: risk assessment / Intestinal research 16(1):4~16
Dong Il Park / 2018 / Asian Organization for Crohn’s and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: management / Intestinal research 16(1):17~25
Dong Il Park / 2018 / Asian Organization for Crohn’s and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: risk assessment / Intestinal research 16(1):4~16
Dong Il Park / 2018 / Asian Organization for Crohn’s and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: management / Intestinal research 16(1):17~25
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Live-attenuated vaccination in patients with inflammatory bowel disease while continuing or after elective switch to vedolizumab
Intestinal research
2024 .07
-
High risk of tuberculosis during infliximab therapy despite tuberculosis screening in inflammatory bowel disease patients in India
Intestinal research
2018 .01
-
Biologics for the Management of Inflammatory Bowel Disease: A Review in Tuberculosis-Endemic Countries
Gut and Liver
2020 .01
-
Changes in Diagnostic Methods for Pulmonary Tuberculosis between 2005 and 2013
Tuberculosis and Respiratory Diseases
2015 .01
-
Treatment of Drug Susceptible Pulmonary Tuberculosis
Tuberculosis and Respiratory Diseases
2015 .01
-
Diagnosis of Pulmonary Tuberculosis: Recent Advances and Diagnostic Algorithms
Tuberculosis and Respiratory Diseases
2015 .01
-
폐결핵의 진단
대한의사협회지
2019 .01
-
Diagnosis and treatment of multidrug-resistant tuberculosis
Journal of Yeungnam Medical Science
2020 .01
-
폐결핵 치료의 최신지견
대한의사협회지
2019 .01
-
의료기관에서의 결핵예방과 결핵환자 격리
대한의사협회지
2019 .01
-
The Correlation Between Alcohol Use Disorder and Tuberculosis
대한의생명과학회지
2024 .12
-
A Pilot Project of Systematic Tuberculosis Screening in the Elderly in a South Korean Province
Tuberculosis and Respiratory Diseases
2019 .01
-
Clinical Use of Measuring Trough Levels and Antibodies against Infliximab in Patients with Pediatric Inflammatory Bowel Disease
Gut and Liver
2017 .01
-
Factors Associated with the Immunogenicity of Anti-Tumor Necrosis Factor Agents in Pediatric Patients with Inflammatory Bowel Disease
Gut and Liver
2021 .01
-
Tuberculosis Infection and Latent Tuberculosis
Tuberculosis and Respiratory Diseases
2016 .01
-
Knowledge, Attitudes, and Practices Regarding Tuberculosis in Timor-Leste: Results From the Demographic and Health Survey 2016
예방의학회지
2019 .01
-
Impact of Pulmonary Tuberculosis on the EGFR Mutational Status and Clinical Outcome in Patients with Lung Adenocarcinoma
Cancer Research and Treatment
2019 .01
-
Delays in the diagnosis and treatment of tuberculosis during the COVID-19 outbreak in the Republic of Korea in 2020
Osong Public Health and Research Persptectives
2021 .10
-
A contact investigation after exposure to a child with disseminated tuberculosis mimicking inflammatory bowel disease
Clinical and Experimental Pediatrics
2018 .01
-
Nationwide Treatment Outcomes of Patients With Multidrug/Rifampin-Resistant Tuberculosis in Korea, 2011–2017: A Retrospective Cohort Study (Korean TB-POST)
Journal of Korean Medical Science
2023 .02
이 논문의 저자 정보
최근 본 자료
댓글(0)
0